Jennison Associates
QDEL icon

Jennison Associates’s QuidelOrtho QDEL Stock Holding History

Jennison Associates’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-9,291
Closed -$2.08M – 681
2020
Q2 		$2.08M Buy
9,291
+3,764
+68% +$590K ﹤0.01% 467
2020
Q1 		$541K Buy
+5,527
New +$447K ﹤0.01% 555

Other funds holding QDEL

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Jennison Associates's QDEL Position: Q3 2020 in Review

Jennison Associates sold out of QuidelOrtho (QDEL) in Q3 2020, closing a stake of 9,291 shares — an estimated $2.08M sold.

Jennison Associates first reported a position in QDEL in Q1 2020 and held it in 2 quarters. The position peaked at $2.08M in Q2 2020. 399 funds tracked by Wall St. Rank hold QDEL as of Q3 2020.

  • Jennison Associates reported no remaining QuidelOrtho position as of Q3 2020 after selling out during the quarter.
  • Jennison Associates sold 9,291 QuidelOrtho shares in Q3 2020, an estimated $2.08M.
  • Jennison Associates first reported a position in QuidelOrtho in Q1 2020 and held it in 2 quarters.
  • Jennison Associates's QuidelOrtho position peaked at $2.08M in Q2 2020.
  • 399 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2020.

Based on Jennison Associates's 13F filing for Q3 2020, filed 4 Nov 2020.